Navigation Links
Four Medical Centers Awarded Funds to Improve Outcomes Research for Heart Disease and Stroke
Date:11/5/2008

DALLAS, Nov. 5 /PRNewswire-USNewswire/ -- The American Heart Association and its Pharmaceutical Roundtable have awarded grants totaling $14.5 million for the Outcomes Research Centers initiative. The project will provide a network for cardiovascular and stroke research focusing on the end results, or outcomes, of healthcare for people with or at risk for heart disease and stroke.

The initiative is supported in part by a generous gift from American Heart Association national board member David Spina and his wife, Stevie Spina, of Wayland, Mass.

The award recipients are:

-- Duke University, Durham, N.C. - Center Director: Eric Peterson, M.D.,

M.P.H.

-- Saint Luke's Mid America Heart Institute, Kansas City, Mo. - Center

Director: John Spertus, M.D., M.P.H.

-- Stanford University School of Medicine, Stanford, Calif. - Center

Director: Mark Hlatky, M.D.

-- University of California, Los Angeles, Calif. - Center Director: Barbara

Vickrey, M.D., M.P.H.

It's expected that the interaction among the centers will provide in-depth knowledge and support breakthroughs in outcomes research, while uncovering challenges and successful mechanisms for active collaboration among research centers.

Over the next four years, these four centers will conduct research to determine what interventions, environments, patient factors and other issue most influence improvements in healthcare outcomes for heart disease and stroke patients. Center investigators will meet regularly and share information with each other, as well as provide training for research fellows.

The Outcomes Centers research will explore those interventions and activities that work best and provide the most value in improving healthcare outcomes. The results of the collaborative will ultimately contribute to informed practice and policy decisions by patients, providers, payers and legislators.

These awards are effective Oct. 1, 2008, and will be funded through Sept. 30, 2012.

The American Heart Association Pharmaceutical Roundtable (PRT) is a strategic coalition of ten leading Pharmaceutical companies that support the American Heart Association's mission to build healthier lives, free of cardiovascular diseases and stroke through collective funding of research, patient education, and public and professional programs. Since its inception in 1988, this premier corporate funding group for the National Research Program has committed over $55 million to cardiovascular and stroke research.


'/>"/>
SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Dynamics Research Corporation Awarded $11.4 Million Medical Healthcare Program Management Contract
2. ATS Medical to Participate at the Rodman & Renshaw Annual Global Investment Conference
3. New Vaccines for Adults: Which do you Need? From Harvard Medical School
4. International Medical Corps Continues Delivering Emergency Relief in Democratic Republic of Congo as Potential for Renewed Fighting Threatens to Deepen Crisis
5. Misonix Subsidiary, Sonora Medical Systems, Announces a Major Ultrasound Probe Study
6. Parker Acquires Medical Gas Delivery Product Line, Expanding Its Dental Equipment Offering
7. Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test
8. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
9. ATS Medical Announces Third Quarter Results
10. Interview with Dr. Elisabeth Hager, CEO of Balan Biomedical, Inc., to Air Nationally on Sky Radio
11. DRE Medical Equipment Repeats as a Fast 50 Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: